Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company's geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific. The Company manufactures and distributes three product categories: mobility and seating, lifestyle and respiratory therapy. It provides medical device solutions for congenital (cerebral palsy, muscular dystrophy and spina bifida), acquired (stroke, spinal cord injury, traumatic brain injury, post-acute recovery and pressure ulcers) and degenerative (amyotrophic lateral sclerosis, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly and bariatric) ailments. The Company sells its products to home medical equipment providers with retail and e-commerce channels, residential living operators, distributors and government health services.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Appliances & Equipment
- Sub-Industry: Health Care Equipment
- Symbol: NYSE:IVC
- CUSIP: 46120310
- Web: www.invacare.com
Capitalization:- Market Cap: $470.44 million
- Outstanding Shares: 32,783,000
Average Prices:- 50 Day Moving Avg: $13.49
- 200 Day Moving Avg: $12.41
- 52 Week Range: $8.00 - $16.65
P/E:- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -84.41
- P/E Growth: -1.22
Sales & Book Value:- Annual Revenue: $1.02 billion
- Price / Sales: 0.46
- Book Value: $12.43 per share
- Price / Book: 1.15
Dividend:- Annual Dividend: $0.05
- Dividend Yield: 0.3%
Profitability:- EBIDTA: ($8,170,000.00)
- Net Margins: -4.09%
- Return on Equity: -8.18%
- Return on Assets: -3.94%
Debt:- Debt-to-Equity Ratio: 0.35%
- Current Ratio: 1.85%
- Quick Ratio: 1.24%
Misc:- Average Volume: 288,271 shs.
- Beta: 2.06
- Short Ratio: 27.33
Frequently Asked Questions for Invacare (NYSE:IVC)
What is Invacare's stock symbol?
Invacare trades on the New York Stock Exchange (NYSE) under the ticker symbol "IVC."
How often does Invacare pay dividends? What is the dividend yield for Invacare?
Invacare announced a quarterly dividend on Thursday, May 18th. Investors of record on Monday, July 3rd will be given a dividend of $0.0125 per share on Friday, July 14th. This represents a $0.05 dividend on an annualized basis and a dividend yield of 0.35%. The ex-dividend date of this dividend is Thursday, June 29th. View Invacare's Dividend History.
How were Invacare's earnings last quarter?
Invacare Co. (NYSE:IVC) announced its earnings results on Monday, May, 8th. The company reported ($0.47) EPS for the quarter, topping analysts' consensus estimates of ($0.53) by $0.06. The business earned $231.70 million during the quarter, compared to the consensus estimate of $226.71 million. Invacare had a negative return on equity of 8.18% and a negative net margin of 4.09%. The firm's quarterly revenue was down 10.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.25) EPS. View Invacare's Earnings History.
Where is Invacare's stock going? Where will Invacare's stock price be in 2017?
2 brokerages have issued 12-month price objectives for Invacare's shares. Their forecasts range from $17.00 to $17.00. On average, they anticipate Invacare's share price to reach $17.00 in the next twelve months. View Analyst Ratings for Invacare.
Who are some of Invacare's key competitors?
Some companies that are related to Invacare include Orthofix International NV (OFIX), Intersect ENT (XENT), Lantheus Holdings (LNTH), GenMark Diagnostics (GNMK), Cryolife (CRY), AxoGen (AXGN), Exactech (EXAC), Syneron Medical (ELOS), Accuray Incorporated (ARAY), Cutera (CUTR), RTI Surgical (RTIX), Corindus Vascular Robotics (CVRS), AcelRx Pharmaceuticals (ACRX), Neovasc Inc (US) (NVCN), IRIDEX (IRIX), Cogentix Medical (CGNT), T2 Biosystems (TTOO) and Iradimed Corp (IRMD).
Who owns Invacare stock?
Invacare's stock is owned by many different of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (8.72%), Dimensional Fund Advisors LP (8.24%), Brandes Investment Partners LP (6.23%), Heartland Advisors Inc. (5.30%), Hotchkis & Wiley Capital Management LLC (4.13%) and Royce & Associates LP (3.74%). Company insiders that own Invacare stock include Anthony Laplaca, Baiju R Shah, C Martin Harris, Clifford D Nastas, Dale C Laporte, Dean J Childers, Matthew E Monaghan, Michael F Delaney and Robert K Gudbranson. View Institutional Ownership Trends for Invacare.
Who sold Invacare stock? Who is selling Invacare stock?
Invacare's stock was sold by a variety of institutional investors in the last quarter, including Heartland Advisors Inc., Granahan Investment Management Inc. MA, Goldman Sachs Group Inc., Morgan Stanley, TIAA CREF Investment Management LLC, Hotchkis & Wiley Capital Management LLC, Netols Asset Management Inc. and Nationwide Fund Advisors. Company insiders that have sold Invacare stock in the last year include C Martin Harris and Dale C Laporte. View Insider Buying and Selling for Invacare.
Who bought Invacare stock? Who is buying Invacare stock?
Invacare's stock was acquired by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Boston Partners, Royce & Associates LP, Brandes Investment Partners LP, Dimensional Fund Advisors LP, MARSHALL WACE ASIA Ltd, Marshall Wace North America L.P. and Schwab Charles Investment Management Inc.. Company insiders that have bought Invacare stock in the last two years include Anthony Laplaca, Baiju R Shah, Clifford D Nastas, Dean J Childers, Matthew E Monaghan and Robert K Gudbranson. View Insider Buying and Selling for Invacare.
How do I buy Invacare stock?
Shares of Invacare can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Invacare stock cost?
One share of Invacare stock can currently be purchased for approximately $14.35.
Consensus Ratings for Invacare (NYSE:IVC) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.| Ratings Breakdown: | 2 Buy Ratings |
| Consensus Rating: | Buy (Score: 3.00) |
| Consensus Price Target: | $17.00 (18.47% upside) |
Analysts' Ratings History for Invacare (NYSE:IVC)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 4/28/2017 | Stephens | Upgrade | Equal Weight -> Overweight | | High |  |
| 10/6/2016 | KeyCorp | Set Price Target | Buy | $17.00 | N/A | |
(Data available from 5/27/2015 forward)
Earnings History for Invacare (NYSE:IVC)Earnings History by Quarter for Invacare (NYSE:IVC)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 5/8/2017 | Q1 17 | ($0.53) | ($0.47) | $226.71 million | $231.70 million | View | Listen | |
| 2/9/2017 | Q416 | ($0.30) | ($0.46) | $262.53 million | $246.70 million | View | Listen | |
| 10/31/2016 | Q316 | ($0.20) | ($0.37) | $271.47 million | $268.15 million | View | Listen | |
| 7/28/2016 | Q216 | ($0.24) | ($0.33) | $270.10 million | $275.00 million | View | Listen | |
| 4/28/2016 | Q116 | ($0.22) | ($0.25) | $272.17 million | $257.60 million | View | N/A | |
| 2/11/2016 | Q415 | ($0.16) | ($0.06) | $284.83 million | $283.26 million | View | Listen | |
| 10/22/2015 | Q315 | ($0.22) | ($0.13) | $286.63 million | $283.80 million | View | Listen | |
| 7/23/2015 | Q215 | ($0.20) | ($0.23) | $296.07 million | $286.30 million | View | Listen | |
| 4/23/2015 | Q115 | ($0.29) | ($0.21) | $275.85 million | $289.00 million | View | N/A | |
| 2/5/2015 | Q414 | ($0.23) | ($0.12) | $310.40 million | $318.20 million | View | N/A | |
| 10/23/2014 | Q314 | ($0.26) | ($0.56) | $331.60 million | $320.50 million | View | N/A | |
| 7/24/2014 | Q214 | ($0.28) | ($0.36) | $327.85 million | $331.31 million | View | N/A | |
| 4/24/2014 | Q114 | ($0.22) | ($0.49) | $326.90 million | $309.10 million | View | N/A | |
| 2/6/2014 | Q413 | ($0.18) | $0.19 | $336.20 million | $334.99 million | View | N/A | |
| 10/24/2013 | Q313 | ($0.26) | ($0.18) | $333.10 million | $341.20 million | View | N/A | |
| 7/25/2013 | Q2 2013 | ($0.20) | ($0.27) | $320.00 million | $351.80 million | View | N/A | |
| 4/25/2013 | Q1 2013 | ($0.09) | ($0.36) | $310.00 million | $337.60 million | View | N/A | |
| 2/8/2013 | Q4 2012 | $0.25 | $0.21 | $422.70 million | $360.42 million | View | N/A | |
| 10/25/2012 | | $0.31 | $0.34 | | | View | N/A | |
| 7/26/2012 | | $0.30 | $0.30 | | | View | N/A | |
| 2/2/2012 | | $0.66 | $0.72 | | | View | N/A | |
| 7/28/2011 | | $0.46 | $0.45 | | | View | N/A | |
| 4/28/2011 | | $0.25 | $0.32 | | | View | N/A | |
| 2/3/2011 | | $0.63 | $0.65 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Invacare (NYSE:IVC)2017 EPS Consensus Estimate: ($1.33)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 1 | ($0.53) | ($0.53) | ($0.53) |
| Q2 2017 | 1 | ($0.39) | ($0.39) | ($0.39) |
| Q3 2017 | 1 | ($0.24) | ($0.24) | ($0.24) |
| Q4 2017 | 1 | ($0.17) | ($0.17) | ($0.17) |
(Data provided by Zacks Investment Research)
Current Dividend Information for Invacare (NYSE:IVC)| Next Dividend: | 7/14/2017 |
| Annual Dividend: | $0.05 |
| Dividend Yield: | 0.35% |
| Dividend Growth: | 0.00% (3 Year Average) |
| Payout Ratio: | -3.79% (Trailing 12 Months of Earnings)
-4.17% (Based on This Year's Estimates)
-29.41% (Based on Next Year's Estimates)
|
Dividend History by Quarter for Invacare (NYSE:IVC)| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 5/18/2017 | quarterly | $0.01 | 0.34% | 6/29/2017 | 7/3/2017 | 7/14/2017 |
| 2/21/2017 | quarterly | $0.01 | 0.41% | 3/30/2017 | 4/3/2017 | 4/13/2017 |
| 11/17/2016 | quarterly | $0.01 | 0.42% | 12/30/2016 | 1/4/2017 | 1/13/2017 |
| 8/26/2016 | quarterly | $0.01 | 0.42% | 10/11/2016 | 10/13/2016 | 10/21/2016 |
| 5/19/2016 | quarterly | $0.01 | 0.48% | 6/30/2016 | 7/5/2016 | 7/13/2016 |
| 2/18/2016 | quarterly | $0.01 | 0.4% | 4/1/2016 | 4/5/2016 | 4/13/2016 |
| 11/20/2015 | quarterly | $0.01 | 0.26% | 12/30/2015 | 1/4/2016 | 1/13/2016 |
| 8/11/2015 | quarterly | $0.01 | 0.3% | 9/30/2015 | 10/2/2015 | 10/13/2015 |
| 5/14/2015 | quarterly | $0.01 | 0.23% | 6/30/2015 | 7/2/2015 | 7/13/2015 |
| 2/13/2015 | quarterly | $0.01 | 0.29% | 3/31/2015 | 4/3/2015 | 4/13/2015 |
| 11/21/2014 | quarterly | $0.01 | 0.32% | 12/31/2014 | 1/5/2015 | 1/14/2015 |
| 8/12/2014 | quarterly | $0.01 | 0.32% | 9/30/2014 | 10/2/2014 | 10/10/2014 |
| 5/15/2014 | quarterly | $0.01 | 0.3% | 7/1/2014 | 7/3/2014 | 7/14/2014 |
| 2/13/2014 | quarterly | $0.01 | 0.26% | 4/1/2014 | 4/3/2014 | 4/11/2014 |
| 11/15/2013 | quarterly | $0.01 | 0.23% | 12/31/2013 | 1/3/2014 | 1/13/2014 |
| 8/13/2013 | quarterly | $0.01 | 0.31% | 10/1/2013 | 10/3/2013 | 10/11/2013 |
| 5/16/2013 | quarterly | $0.01 | 0.34% | 7/2/2013 | 7/5/2013 | 7/15/2013 |
| 2/14/2013 | quarterly | $0.01 | 0.34% | 4/1/2013 | 4/3/2013 | 4/12/2013 |
(Data available from 1/1/2013 forward)
Insider Trading and Institutional Ownership History for Invacare (NYSE:IVC)Insider Ownership Percentage: 2.60%
Insider Trades by Quarter for Invacare (NYSE:IVC)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 5/16/2017 | Dale C. Laporte | Director | Sell | 2,737 | $14.95 | $40,918.15 | |
| 11/16/2016 | Dale C. Laporte | Director | Sell | 375 | $11.90 | $4,462.50 | |
| 11/2/2016 | Baiju R. Shah | Director | Buy | 1,000 | $9.04 | $9,040.00 | |
| 11/2/2016 | Matthew E Monaghan | Chairman | Buy | 11,000 | $9.00 | $99,000.00 | |
| 8/4/2016 | C Martin Harris | Director | Sell | 475 | $11.49 | $5,457.75 | |
| 5/17/2016 | Dale C Laporte | Director | Sell | 375 | $10.33 | $3,873.75 | |
| 5/16/2016 | Dean J Childers | SVP | Buy | 10,000 | $10.40 | $104,000.00 | |
| 5/6/2016 | Clifford D Nastas | Director | Buy | 5,000 | $11.01 | $55,050.00 | |
| 5/3/2016 | Matthew E Monaghan | CEO | Buy | 4,500 | $11.39 | $51,255.00 | |
| 5/2/2016 | Anthony Laplaca | VP | Buy | 1,000 | $11.23 | $11,230.00 | |
| 5/2/2016 | Baiju R Shah | Director | Buy | 2,000 | $11.27 | $22,540.00 | |
| 2/29/2016 | Anthony Laplaca | VP | Buy | 1,000 | $12.38 | $12,380.00 | |
| 2/29/2016 | Matthew E Monaghan | CEO | Buy | 8,000 | $12.31 | $98,480.00 | |
| 2/29/2016 | Robert K Gudbranson | CFO | Buy | 4,200 | $12.01 | $50,442.00 | |
| 12/10/2015 | Michael F. Delaney | Director | Sell | 1,000 | $19.05 | $19,050.00 | |
| 12/8/2014 | C Martin Harris | Director | Sell | 1,125 | $16.22 | $18,247.50 | |
| 12/9/2013 | C Martin Harris | Director | Sell | 1,775 | $22.15 | $39,316.25 | |
| 5/6/2013 | Joseph B Richey II | SVP | Buy | 1,000 | $13.74 | $13,740.00 | |
| 5/1/2013 | Gerald B Blouch | CEO | Buy | 1,000 | $13.59 | $13,590.00 | |
| 4/30/2013 | Aaron Malachi Mixon III | Chairman | Buy | 4,300 | $13.22 | $56,846.00 | |
| 4/30/2013 | Louis F J Slangen | SVP | Buy | 1,000 | $13.05 | $13,050.00 | |
| 4/29/2013 | Aaron Malachi Mixon III | Chairman | Buy | 45,700 | $12.53 | $572,621.00 | |
| 4/29/2013 | Dale C Laporte | Director | Buy | 1,000 | $12.24 | $12,240.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Invacare (NYSE:IVC)
Latest Headlines for Invacare (NYSE:IVC)
| Source: |
|
| Date | Headline |
|---|
 | Invacare to Present at Jefferies 2017 Global Healthcare Conference
finance.yahoo.com - May 26 at 2:34 AM |
| Invacare Continues Realignment as Part of Its Ongoing Transformation
finance.yahoo.com - May 24 at 5:55 PM |
 | Bravo Promotes Chris Yessayan to President
www.marketwatch.com - May 23 at 5:36 PM |
 | Invacare Co. (IVC) Director Sells $40,918.15 in Stock
www.americanbankingnews.com - May 18 at 8:33 PM |
| Invacare Co. (IVC) Announces Quarterly Dividend of $0.01
www.americanbankingnews.com - May 18 at 2:14 PM |
 | Balter Liquid Alternatives, LLC Buys Craft Brew Alliance Inc, Nuance Communications Inc, ...
www.nasdaq.com - May 13 at 5:37 PM |
| ETFs with exposure to Invacare Corp. : May 11, 2017
finance.yahoo.com - May 11 at 8:19 PM |
| KeyCorp Analysts Reduce Earnings Estimates for Invacare Co. (IVC)
www.americanbankingnews.com - May 11 at 8:32 AM |
| Edited Transcript of IVC earnings conference call or presentation 9-May-17 12:30pm GMT
finance.yahoo.com - May 10 at 11:22 PM |
| Invacare Corp. :IVC-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017
finance.yahoo.com - May 10 at 1:12 PM |
 | Invacare Corporation's (IVC) CEO Matt Monaghan on Q1 2017 Results - Earnings Call Transcript
seekingalpha.com - May 9 at 5:48 PM |
| Invacare Co. (IVC) Issues Quarterly Earnings Results, Misses Estimates By $0.01 EPS
www.americanbankingnews.com - May 9 at 12:17 AM |
| Invacare Co. (IVC) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS
www.americanbankingnews.com - May 8 at 11:53 PM |
 | Invacare reports 1Q loss
marketbeat.com - May 8 at 6:22 PM |
 | BRIEF-Invacare Q1 GAAP loss per share $0.52
www.reuters.com - May 8 at 5:40 PM |
| Invacare Reports Results for the First Quarter 2017
finance.yahoo.com - May 8 at 5:40 PM |
| Invacare misses by $0.08
seekingalpha.com - May 8 at 5:17 PM |
| Invacare Introduces ‘Outcomes by Design’ Program for Post-Acute Care Facilities
finance.yahoo.com - May 3 at 10:26 PM |
| Invacare (IVC) Earning Somewhat Positive Press Coverage, Analysis Finds
www.americanbankingnews.com - April 29 at 10:47 PM |
 | Why Invacare Corporation's Shares Rallied 12.1% Today
www.fool.com - April 28 at 6:58 PM |
| Why Invacare Corporation's Shares Rallied 12.1% Today
finance.yahoo.com - April 28 at 6:58 PM |
| Invacare Co. (IVC) Upgraded by Stephens to Overweight
www.americanbankingnews.com - April 28 at 8:01 AM |
| BRIEF-Invacare says completed 2 milestones required to initiate FDA's re-inspection
www.reuters.com - April 27 at 6:36 PM |
| Invacare Reports Completion of Consent Decree Milestones
finance.yahoo.com - April 27 at 6:36 PM |
| Very Favorable News Coverage Very Likely to Affect Invacare (IVC) Share Price
www.americanbankingnews.com - April 25 at 9:15 AM |
 | Negative Pressure Wound Therapy (NPWT) Market 12 Companies Product Pipeline Developments Published in 2017 Report at ReportsnReports
www.prnewswire.com - April 20 at 11:06 PM |
| Somewhat Favorable News Coverage Extremely Likely to Impact Invacare (IVC) Share Price
www.americanbankingnews.com - April 20 at 11:09 AM |
| Invacare Corp. – Value Analysis (NYSE:IVC) : April 19, 2017
finance.yahoo.com - April 19 at 5:53 PM |
| Portable Oxygen Concentrators Market: North America Estimated to Account for ...
www.prnewswire.com - April 18 at 5:29 PM |
| Invacare Corp. breached its 50 day moving average in a Bullish Manner : IVC-US : April 18, 2017
finance.yahoo.com - April 18 at 10:58 AM |
| Zacks: Invacare Co. (IVC) Given Consensus Recommendation of "Strong Buy" by Brokerages
www.americanbankingnews.com - April 17 at 10:34 PM |
| Invacare (IVC) Earning Favorable News Coverage, Analysis Finds
www.americanbankingnews.com - April 17 at 8:21 PM |
| Favorable Media Coverage Very Likely to Impact Invacare (IVC) Share Price
www.americanbankingnews.com - April 14 at 10:49 PM |
| BRIEF-Invacare says received notification from FDA that it accepted recent second certification report
www.reuters.com - April 14 at 5:56 PM |
| Invacare Corporation to Host Conference Call and Webcast to Discuss First Quarter 2017 Financial Results
finance.yahoo.com - April 13 at 9:27 AM |
| Invacare Co. (IVC) Upgraded to "Hold" by Zacks Investment Research
www.americanbankingnews.com - April 12 at 12:50 AM |
| Invacare Co. (IVC) Coverage Initiated at Stephens
www.americanbankingnews.com - April 4 at 6:00 PM |
| The Rehab Equipment Market Will Reach USD 14.91 Billion by 2021
www.marketwatch.com - March 31 at 6:01 PM |
| Invacare Corporation (IVC) Ex-Dividend Date Scheduled for March 30, 2017 - Nasdaq
www.nasdaq.com - March 31 at 7:50 AM |
| Zacks: Invacare Co. (IVC) Receives Consensus Rating of "" from Analysts
www.americanbankingnews.com - March 30 at 12:14 PM |
| Pressure Relief Devices Market Size & Forecast By Type (Low-Tech Devices , High-Tech Devices ), And Trend Analysis From 2014 - 2025
finance.yahoo.com - March 28 at 11:03 AM |
 | Annual Needham Healthcare Conference - Business Wire (press release)
www.businesswire.com - March 26 at 9:13 AM |
| Invacare Corporation to Present at 16th Annual Needham Healthcare Conference
finance.yahoo.com - March 24 at 9:32 AM |
| INVACARE CORP Financials
finance.yahoo.com - March 16 at 6:49 PM |
| Pressure Relief Devices Market Size to Reach $4.1 Billion by 2025: Grand View Research, Inc.
www.marketwatch.com - March 14 at 10:13 PM |
| INVACARE CORP Files SEC form 10-K, Annual Report
biz.yahoo.com - March 10 at 7:11 PM |
| Invacare Declares Quarterly Dividend
finance.yahoo.com - February 22 at 12:33 PM |
 | EARNINGS SUMMARY: Details of Invacare Corp Q4 Earnings Report
www.rttnews.com - February 9 at 11:58 PM |
| Invacare Corporation Announces Financial Results for the Fourth Quarter and Full Year Ended December …
finance.yahoo.com - February 9 at 11:58 PM |
 | Invacare Corporation Announces Financial Results for the Fourth Quarter and Full Year Ended December 31, 2016
us.rd.yahoo.com - February 9 at 11:58 PM |
Invacare (IVC) Chart for Saturday, May, 27, 2017
